Theranexus : THERANEXUS PUBLISHES ITS 2023 FULL-YEAR RESULTS AND PRESENTS ITS PROGRESS REPORT

Lyon, France – 29 April 2024 – 6pm CET – Theranexus, a biopharmaceutical company innovating in the treatment of rare neurological diseases, today publishes its results for the year ending 31...

Related Keywords

Paris ,France General ,France ,Portejoie ,Haute Normandie ,United States ,American ,French ,Mathieu Charv ,Thierry Lambert ,Inserm Transfert ,American Beyond Batten Disease Foundation ,Drug Administration ,Research Tax Credit ,Kedge Business School ,Claude Bernard University Lyon ,Atomic Energy Commission ,Access Program ,European Medicines Agency ,Young ,Linkedin ,Twitter ,Theranexus Chairman ,Tax Credit ,Christine Placet ,Chief Financial ,Chief Financial Officer ,Coave Therapeutics ,Kedge Business ,Expanded Access Program ,French Alternative Energies ,Euronext Growth ,Markets ,